UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry 
Nvidia Partners With Fanuc and Yaskawa to Accelerate AI Robotics in Japan 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks 
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
Uber to Acquire Delivery Hero in $14.8 Billion Deal to Expand Global Food Delivery Business 
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes 
United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs 
Hyundai Takes Full Control of Boston Dynamics to Accelerate Humanoid Robot and AI Strategy 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback 
Dutch healthcare technology giant Philips (EPA:TTEF) forecasted a 1% to 3% increase in comparable sales for 2025 despite ongoing challenges in China. The company missed market expectations for Q4 2024, reporting €5.04 billion ($5.27 billion) in revenue, slightly below analysts’ projections of €5.07 billion.
Philips attributed the weaker performance to a double-digit decline in China sales, which is expected to continue in 2025. The forecast includes a mid- to high-single-digit drop in Chinese revenue and the impact of new U.S.-China tariffs. CEO Roy Jakobs previously stated that China’s contribution to total revenue has fallen to around 10%, down from over 13% earlier in the decade. The company employs over 7,000 people in the country.
Despite the decline, Philips maintained its commitment to growth, with adjusted EBITA reaching €679 million for Q4, slightly below the €683 million analysts expected. The company proposed an annual dividend of €0.85 per share, consistent with the previous year.
Philips, known for its diverse portfolio from medical imaging systems to consumer electronics, had already lowered its 2024 sales forecast in October due to weak demand in China. The company’s ability to navigate global economic shifts, supply chain disruptions, and geopolitical challenges will be critical for its 2025 performance.
With a focus on stabilizing sales and overcoming market headwinds, Philips continues to adapt its strategy amid evolving economic conditions.
